ROSEN, A TOP RANKED LAW FIRM, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
FDA Accepts Amgen's Supplemental New Drug Application For Otezla® For Adults With Mild-To-Moderate Plaque Psoriasis Biotech Investing
Bristol Myers Squibb to Take Part in the 2021 Bank of America Securities Health Care Conference Biotech Investing
BLU Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BELLUS Health Inc. Investors of Class Action and Lead Plaintiff Deadline: May 17, 2021 Biotech Investing
Wellteq Receives OTC Listed Trading Symbol WTEQF and Announces Application to Up List on OTCQB Biotech Investing
Bristol Myers Squibb Presents New Clinical and Real-World Data on Mavacamten and Obstructive Hypertrophic Cardiomyopathy at Upcoming American College of Cardiology's 70th Annual Scientific Session Biotech Investing
BLU Looming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BELLUS Health Inc. Investors of Class Action and Lead Plaintiff Deadline: May 17, 2021 Biotech Investing
